Corbus Pharmaceuticals I...

NASDAQ: CRBP · Real-Time Price · USD
9.38
0.13 (1.41%)
At close: Aug 18, 2025, 10:00 AM

Corbus Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-57.95M -50.29M -40.21M -38.7M -34.97M -33.76M -44.6M -47.46M -46.19M -50.65M -42.35M -41.73M -35.12M -39.01M -45.64M -43.99M -76.71M -97.68M
Depreciation & Amortization
-241.69K 529.31K 600K 601.98K 652.48K 610.82K 641K 867.24K 1.09M 1.3M 1.49M 1.49M 1.53M 1.58M 1.64M 1.69M 1.62M 1.66M
Stock-Based Compensation
7.15M 5.59M 4.86M 4.03M 2.6M 3.43M 3.47M 3.94M 4.46M 5.15M 5.72M 6.24M 7.5M 8.49M 9.48M 10.03M 11.06M 11.9M
Other Working Capital
-8.21M -7.14M -7.18M -463.32K 2.16M 438.53K 3.07M 1.56M 3.54M 3.2M -3.77M -6.31M -8.23M -9.27M -9.74M -8.4M -2.33M 4.32M
Other Non-Cash Items
-2.27M 319.3K 2.26M 5.56M 6.24M 4.8M 3.1M 248.12K 55.61K 627.49K 1.62M 2.23M 2.4M 1.77M 950.61K 693.91K 832.22K 695.38K
Deferred Income Tax
n/a n/a n/a -2.59M -2.73M -2.8M -2.8M -209.85K -78.27K n/a n/a 282.9K 1.19M 1.15M 1.08M 1.07M 161.64K 204.61K
Change in Working Capital
-4.58M -5.09M -5.58M -2.04M 1.82M 1.18M 4.09M 5.07M 3.04M 1.53M -4.02M -8.31M -9.18M -10.97M -15.7M -26.2M -21.78M -10.68M
Operating Cash Flow
-57.9M -50.25M -41.79M -36.86M -30.1M -28.95M -36.1M -37.55M -37.62M -42.04M -37.54M -39.79M -31.69M -36.99M -48.18M -56.71M -84.82M -93.89M
Capital Expenditures
n/a 2.00 2.00 2.00 2.00 n/a n/a -13.42M -13.44M -13.44M -13.46M -89.16K -75.72K -67.62K -54.17K 52.09K -4.71K -20.89K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a 0.45 1.00 8.1K 8.1K 7.05M 7.05M 7.05M 7.05M 7.7K 6.4K 2.6K
Purchase of Investments
-105.31M -112.51M -180.8M -172.89M -140.68M -126.47M -33.88M -28.16M -43.91M -93.18M -86.34M -98.74M -83.1M -36.31M -87.27M -77.27M -70.53M -57.43M
Sales Maturities Of Investments
134.54M 107.56M 59.49M 53.24M 47.29M 58.33M 69.53M 65.19M 64.07M 85.83M 116.42M 113.9M 104.52M 63.33M 13.88M 7.02M n/a n/a
Other Investing Acitivies
n/a -16.44K -114.67K -104.29K -93.39K -68.14K 30.09K 13.44M 13.44M 13.44M 13.49M -6.96M 44.67K 40.38K n/a 7.03M 6.4K 2.6K
Investing Cash Flow
29.23M -4.95M -121.31M -119.65M -93.39M -68.14M 35.64M 37.03M 20.17M -7.34M 30.07M 15.12M 21.37M 26.97M -73.42M -70.19M -70.53M -57.45M
Debt Repayment
-10.9M -13.16M -15.48M -17.31M -7.15M -5.04M -2.87M -808.54K -178.55K -356.56K -533.62K 1.00 8.01K 32.53K 57.78K n/a 18.75M 18.73M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a 6.69M n/a -73.84K -73.84K -6.76M -73.84K n/a n/a n/a n/a n/a n/a n/a -1.82M -2.49M -4.91M -5.1M
Financial Cash Flow
25.03M 60M 166.58M 164.69M 138.82M 103.88M -2.82M -681.5K 28.3K -319.5K -533.62K 1.00 8.01K 82.53K 60.82M 81.79M 128.62M 172.35M
Net Cash Flow
-3.64M 4.8M 3.57M 8.27M 15.43M 6.87M -3.28M -1.19M -17.42M -49.7M -8M -24.68M -10.31M -9.94M -60.78M -45.1M -26.72M 21.02M
Free Cash Flow
-57.9M -50.25M -41.79M -36.86M -30.1M -28.95M -36.1M -50.97M -51.05M -55.49M -51M -39.88M -31.77M -37.06M -48.24M -56.65M -84.82M -93.91M